Medical University of South Carolina: Investigational Drug Services — Charleston, South Carolina

Medical University of South Carolina: Investigational Drug Services is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Medical University of South Carolina: Investigational Drug Services has participated in 2 clinical trials.

Therapeutic areas: Sickle Cell Disease, Venous Thromboembolism.

Sponsors: Pfizer, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical University of South Carolina: Investigational Drug Services?

Medical University of South Carolina: Investigational Drug Services has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical University of South Carolina: Investigational Drug Services conducted?

Medical University of South Carolina: Investigational Drug Services has 2 clinical trials on record. Their work covers Sickle Cell Disease, Venous Thromboembolism.

Is Medical University of South Carolina: Investigational Drug Services accredited by Crixeo Health?

Medical University of South Carolina: Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical University of South Carolina: Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.